Публикуется по изданию: Н. А. Корнетов. Сертралин (золофт): новый в России селективный антидепрессант и его значение в терапии типичных депрессивных расстройств
Скачать 469.84 Kb.
|
| N-methyl-4-(3,4-diclorophenil) –1,2,3,4- tetrahidro-1-naphtilamin, a new uptake inhibitor with selectivity for serotonin // J. Pharmacol. Exp. Ther.-1983a.-Vol. 226.- P. 686-700. 78. Koe B. K., Weissman A., Welch W.M. at al. Sertraline, a new selective inhibitor of serotonin upteike // Psychopharmacol Bull.- 1983b.-Vol.19. P. 687-691. 79. Koe B. K., Vinik F.J. Adaptive changes in central nervous system receptor systems // Ann. Rep. Med. Chem. – 1984. – Vol. 19. –P. 41-50. 80. Koe B. K., Koch S. W., Lebel L.A. et al. Sertraline, a selective inhibitor of serotonin upteike, indduces subsensitivity of beta-adrenoreceptor system of rat brain // Eur. J. Pharmacol. –1987. – Vol. 141. – P.187-194. 81.Koe B. K. Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin re-uptake // J. Clinic. Psychiatry. – 1990. – Vol. 51.-Suppl.B.12.- P. 3-17. 82. Kupfer D.J. Long-term treatment of depression // J. Clinic. Psychiatry. – 1991. – Vol. 52.-Suppl.B.12.- P. 28-34. 83. Kupfer D.J. Management of recurrent depression // J. Clinic. Psychiatry. – 1993. – Vol. 54.-Suppl.2.- P. 29-33. 84. Kupfer. D.J., Freedman D.X. Treatment for depression: “standart” clinical practice as an unexamined topic (comment) // Arch. of General Psychiatry. – 1986. – Vol. 43. –P. 509-511. 85. Kurtz D., Bergstorm R., Goldberg M. et al. Drug interactions between sertraline and desipramine or imipramine (abstract) // J. Clin. Pharmacol. – 1994.-Vol.34.-P.1009-1033. 86. Lamy P.P., Salzman C., Nevis Olesen J. Drug prescribing patterns, risks, and complaince guidelines // Clinical Geriatric Psychopharmacology. 2 Edn./ Ed. C. Salman. – Baltimore: Williams and Wilkins. – 1992. –P. 15-370. 87. Lane R.M. // Мanaging depression in general practic // Brit. Med. J. –1993a.- Vol.306.- P. 272-273. 88. Lane R.M. Antidepressant therapy in the physically ill: a therapeutic opportunity for the selective 5-HT reuptake inhibitors? // J. Psychopharmacol.-1993b.- Vol.7.-Suppl.2.- P. 112-118. 89.Lane R.M. Potential pharmacokinetics interactions of selective serotonin reuptake ingibitors with other drugs // Intern. Clin. Psychopharmacol.-1996.- Vol.11.- Suppl.5 - P. 31-61. 90. Lane R.M., Sweeney M., Henri J. Pharmacotherapy of the depressed patients with cardiovascular or cerebrovascular illness // Brit. J. Clin. Practic.-1994.-Vol.48.-P. 256-262. 91. Latimer P.R., Ravindran A.V. Bernatchez J-P et al. A six month comparison of toleration and efficacy of sertraline and fluoxetine of major depression // Poster presented at XXth Collegium Intern. Neuropsychopharmacol., Melbourne, Australia,1996. 92. Lemberger L., Row H., Bosomworth et al. The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam // Clin. Pharmacol. Ther. – 1988.- Vol. 43. –P. 412-419. 93. Liebowitz M.R. Depression with anxiety and atypical depression // J. Clinic. Psychiatry. – 1993. – Vol. 54.-Suppl.2.- P.10-14. 94. Llerena A., Edman G., Gobaleda J. et al. Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6 // Acta Psychiatr. Scand. – 1993. – Vol. 87. – P. 23-28. 95. Lydiard T., Anton R.E., Cunningham T. Interactions between sertraline and tricyclic antidepressants // Am. J. Psychiatry. - 1993. – Vol. 150. – P. 1125-1126. 96. Mardoch D., McTavich D. Sertraline: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depression and obsessive-compylsive disorder // Drugs. – 1992.-Vol. 44.-P. 604-624. 97. Mattila M.J., Saarialho-Kere U., Mattila M. Acute effects of sertraline, amitriptyline, and placebo on psychomotor performance on healthy subjects over 50 years of age // J. Clinic. Psychiatry. – 1988. – Vol. 49.-Suppl.- P. 52-58. 98. Meltzer H.Y., Lowy M.T. The serotonin hypothesis of depression // Clin. Psychopharmacology: the third generation of progress / Ed. H.Y. Meltzer. – New York: Raven Press. – 1987.- Vol. 52. – P. 513-526. 99. Mendels J. The acute and long-term treatment of major depression // Intern. Clin. Psychopharmacol.-1991.- Vol.7.-Supp2.- P. 21-29. 100. Mendels J., Camera A. Sertralin treatment for premature ejaculation // Neuropsychopharmacology.- 1994.-Vol. 10.-P.189. 101. Mertens C., Bartholome F., Cosyns P. et al. A controlled comparison of sertralin and fluoxetine in acute and continuation treatment of major depression // Presented at 148th Am. Psychiatry Ass., Miami, USA< 20-26 May, 1995. 102. McGrath P.J. Pleminary information about sertraline (Zoloft) – a new, highly, selective, serotonin reuptake inhibitor // Curr. Affect ILL. -1992. – Vol.11. – P. 5-14. 103. Montamat S.C., Cusack B. Overcoming problems with polypharmacy and drug misuse in the elderly // Clin. Geriatr. Med. – 1992. –Vol. 8. – P. 143-158. 104. Montano B.C. Recognition and treatment of depression in a Primary Care Setting // J. Clinic. Psychiatry. – 1994. – Vol. 55.-Suppl.12.- P.18-34. 105. Montgomery S. A. Progress on long-term management - report of an ICANP consensus // Presented at VIIth European College of Neuropsychopharmacology, Jerusalem, Israel,16-21 October, 1994. 106. Montgomery S. Serotonin, sertraline and depression // J. Psychopharmacol.- 1995.-Vol.9.- Suppl.2 - P. 179-184. 107. Montgomery S. A., Asberg M. A new depression scale design to be sensetive to change // Brit. J. Psychiatry.- 1979. – Vol. 134. – P. 382-389. 108. Montgomery S.A., Doogan D.P., Burnside R. The influence of different relapse criteria on the assessment of long-term efficacy of sertraline // Intern. Clin. Psychopharmacol.-1991.- Vol.6.-Suppl.2.- P. 37-46. 109. Moon C.A.L., Wood K., Lane R.M., Jago W. Sertraline and clomipramine in mixed anxiety depression // Presented at the British Ass. Psychopharmacol., Cambrige, UK, July 25-28, 1993. 110.Moon C.A.L., Jago W., Wood K et al. A double-blind comparison of sertralin and clomipramine in the treatment of major depression disorders and associated anxiety in general practice// Poster presented at XIXth Collegium Intern. Neuropsychopharmacol., Washington DC, USA, 17 June-1July 1994. 111. Moon C.A.L., Jago W., Wood K et al. A double-blind comparison of sertralin and clomipramine in the treatment of major depression disorders and associated anxiety in general practice// J. Psychopharmacol.-1994.- Vol.8.-Suppl.3.- P. 171-176. 112. Nebert D.W., Nelson D.R., Adesnic M. et al. The P-450 superfamily: update listing of all genes and recommended nomenclature for the chrosomal loci // DNA Seq. -1989.-Vol.8.-P.1-13. 113. Nebert D.W., Nelson D.R., Coon M.J. et al. The P-450 superfamily: update on new sequences, gene mapping and recommended nomenclature // DNA Cell. Biol. -1991.-Vol.10.-P.1-14. 114. Nelson D.R., Kamataki T., Waxman D.J. et al. The P-450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature // DNA Cell Biol.-1993.-Vol.12.-P.1-51. 115. Nemeroff Ch. B. Evolutionary trends in the pharmacotherapeutic management of depression // J. Clinic. Psychiatry. – 1994. – Vol. 55.-Suppl.12.- P.3-15 . 116. Newhous P.A., Richter E.M. SSRis in depressed elderly: a double-blind comparison of sertralin and fluoxetine in depressed geriatric patients // Presented at VIIth European College of Neuropsychopharmacology, Jerusalem, Israel,16-21 October, 1994a. 117. Newhous P.A., Richter E.M. SSRis in depressed elderly: a double-blind comparison of sertralin and fluoxetine in depressed geriatric outpatients // Poster presented at XIXth Collegium Intern. Neuropsychopharmacol., Washington DC, USA, 17 June-1July 1994b. 118. Olie J.P., Gunn K.P., Katz E Sertraline: Efficacy and toleration in major depression // Presented at XIXth Collegium Intern. Neuropsychopharmacol., Washington DC, USA, 27 June-1 July 1994. 119. Otton S.V., Ball., S.E., Cheung S.W. et al. Comparative inhibition of the polimorphic enzim CYP2D6 by venlafaxine (VF) and other 5HT uptake inhibitors // Clin. Pharmacol. Ther. –1994. – Vol. 55. – P.141. 120. Quitkin F.M., Burnside R., Yurkewiicz L. Positive pattern analysis results in sertraline depression trails // Presented at XVIIIth CINP, Nice, France, June 28- July 2, 1992. 121. Peck C.C., Temple R., Collins J.M. Understanding consequences of concurrent therapies // J. Am. Med. Ass. –1993. Vol. 269. – P. 1550-1552. 122. Peroutka S. J., Sleight A.J., McCarthy B.G. et al. The clinical utility of pharmacological agents that act as serotonin receptor // Journal of Neuropsychiatry. –Vol.1. – P. 253-262. 123. Perucca E., Gatti G., Cippola G et al. Inhibition of diazepam metabolism by fluvoxamine: a pharmacokinetic study in normal volunteers // Clin. Pharmacol. Ther. –1994.- Vol. 56.- P.471-476. 124. Pollock B.G., Perel J.M. Tricyclic antidepressants: contemporary issues for therapeutic practice // Can. J. Psychiatry – 1989. – Vol. 32. – P. 609-617. 125. Preskorn S.H. Pharmacokinetics of antidepressants: why and how they are relevant to treatment // J. Clinic. Psychiatry. – 1993. – Vol. 54.-Suppl.9.- P.14-34. 126. Preskorn S.H. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline // Intern. Clin. Psychopharmacol.-1994.- Vol.9.-Suppl.3.- P. 3-19. 127. Preskorn S.H. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazadone, paroxetine, sertraline and venlafaxine // J. Clinic. Psychiatry. – 1995. – Vol. 56.-Suppl.6.- P.12-21. 128. Preskorn S.H. Clinically relevant Pharmacology of selective serotonin re uptake inhibitors: an overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism // Clin. Pharmacokinet.- 1997.- Vol. 32.- Suppl.1.- P. 1-21. 129. Preskorn S.H., von Moltter L., Alderman J. et al. In vitro and in vivo evaluation of the potencial for desipramine interaction with fluoxetine or sertralin // Presented at the 146th Annual Meeting of the Am. Psychiatry Ass., San Francisco, USA, 20-26 May, 1993. 130. Preskorn S.H., Alderman J., Chung M. et al. Pharmacokinetics of desipramine coadministered with sertralin or fluoxetine // J. Clin. Psychopharmacol.- 1994.-Vol.14.- N 2.- P. 90-98. 131. Rasmussen B.B., Maenpaa J., Pelconen O et al. Selective serotonin reuptake ingibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine // Br. J. Clin. Pharmacology. – 1995. – Vol.39. – P.151-159. 132. Regier D.A., Hirschfeld R.M.A., Goodwin F.K. et al. The NIMN depression awereness, recognition, and treatment programm: structure, aims, and scientific basis// Am. J Psychiatry. - 1988. – Vol. 145. – P. 1351-1357. 133. Reimherr F.W., Chouinard G., Cohn C.K. et al. Antidepressant effcacy of sertralin: a double-blind, placebo and amitriptyline-controlleed multicenter comparison study in outpatients with major depression // J. Clinic. Psychiatry. – 1990. – Vol. 51.-Suppl.B.12.- P. 9-12. 134. Revicki D.A., Turner R.R., Martindale J.J. Reliability and validity of a health-related quality of life battery for evaluating outpatient antidepressant treatment // Quality of life Res.-1992.- Vol.1. - P. 257-266. 135. Reynolds C.F., Kupfer D.J. Sleep research in affective ilness: state of the art circa 1987 // Sleep. – 1987. – Vol. 10. – P. 199-215. 136. Richelson E. Synaptic pharmacology of antidepressant: an update // McLean Hospital Journal.-1988.-Vol.13.- P.67-88. 137. Rickels K., Schweizer E. Clinical overview of serotonin reaptake inhibitors // J. Clinic. Psychiatry. – 1990. – Vol. 51.-Suppl.B.- P. 14-20. 138. Robins E. The final month: A study of 134 persons who committed suicide. – Ney York: Oxford University Press. –198 1.-P. 424. 139. Robins L.N., Kullok P.A. Epidemiological study in suicide. Review of Psychiatry. – Washington DS: Am. Psychiatric Press.- 1988.-Vol. 7. –289-306. 140. Ronfeld R. A., Tremaine L. M., Wilner K.D. Pharmacokinetics of sertralin and N-demethyl metabolite in elderly and young male and female volunteers // Clin. Pharmacokinet.- 1997.- Vol. 32.- Suppl.1.- P. 22-30. 141.Schatzberg A.F. Dosing strategies for antidepressant agents // J. Clinic. Psychiatry. – 1991. – Vol. 52.-Suppl.5.- P. 14-20. 142. Sechter. D., Troy S., Rioux P. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients // Eur. Neuropsycholopharmacol.- 1996.-Vol.6.-Suppl.3. - P.124 143. Skjeblo E., Brosen K. Inhibitors of imipramine metabolism by human liver microsomes // Br. J. Clin. Pharmacol. – 1992. – Vol. 34. – P. 256-261. 144. Spina E., Pollicino A.M., Avenoso A et al. Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects // Ther. Drug Monit. –1993. – Vol. 15. – P. 247. 145. Tompson C. Managment of depression in real-life settings: knowledge gained from large-scale clinical trials // Intern. Clin. Psychopharmacol.-1994a.- Vol.9.-Suppl.3.- P. 21-25. 146. Tompson C., Lane R. Sertraline 50 mg: optimal daily dose in depression // Poster presented at XIXth Collegium Intern. Neuropsychopharmacol., Washington, USA, 27 June-1 July 1994b. 147. Tulloch I.F., Johnson A.M. The pharmacologic profil of paroxetin, a new selective serotonin reuptake ingibitor // J. Clinic. Psychiatry. – 1992. – Vol. 53.-Suppl.2.- P. 7-12. 148. Turner R. Quality of life: experience with sertraline // Intern. Clin. Psychopharmacol.-1994.- Vol.9.-Suppl.3.- P. 27-31. 149. Ustun T.B., Sartorius N. Eds. Menntal illnes in general health care: an international study. – New York : John Wiley & Sons. – 1995. 150. Wamsley J.K., McCabe R.T., McConnel E.J. Sertraline, an antidepressant which inhibits serotonin uptake specifically down regulates beta1 receptors // Psychopharmacology.-1988.- Vol.96.-Suppl.B.- P. 270. 151. Ware J.C., Morewitz J. Diagnosis and treatment of insomnia and depression // J. Clinic. Psychiatry. – 1991. – Vol. 52.-Suppl.6.- P. 55-61. 152. Wells K.B., Stewart A., Hays R.D. et al. The function and well-being of depressed patients: results from the medical outcomes Study // J. Amer. Medical Ass. – 1989. – Vol. 262. – P. 914-919. 153. Warrington S.J. Clinical implications of the pharmacology of sertraline reaptake inhibitors // Int. Clin. Psychopharmacol.- 1992.-Vol.7. Suppl.2- P. 13-21. 154. Wesnes K.A., Forster P.L., Grimwood V. Studies of the potential cognitive interactions between sertraline and haloperidol, carbamazepine and phenytoin in volunteers // Presented at the 34th Annual Meeting of the new clinical drug evaluation unit, Marco, Island, Florida, May 31- June 3, 1994. 155. Wilner K.D., Lazar J.D., Apseloff G. et al. The effects of sertraline on the pharmacodynamics of warfarin in healthy volunteers // Biol. Psych.- 1991.-Vol.29.- P. 354. 156. Winokur A., Sewitch D.E., Phillips J. L. et al. Sleep architecture and mood effects of sertraline in outpatients with mayor depression: a pleminary report // Biol. Psych.- 1991.-Vol.29.- P. 162-163. 157. WHO Mental Health Colloborating Centres. Pharmacotherapy of depressive disorders: a consensus statement // J. Affective Disorders. – 1989. – Vol. 17. – P. 197-198. 158. Van Moffaert M., Bartholome F., Cosyns P. et al. A controlled comparison of sertraline and fluoxetine in the acute and continuation treatment of major depression // Hum. Psycholopharmacol.- 1995.-Vol.10.- P. 393-405. 159. Von Moltke L.L., Greenblatt D.J., Shader R.I. Clinical pharmacokinetics of antidepressants in the elderly: therapeutic implications // Clin. Pharmacokinet.- 1993.- Vol. 24.- P. 141-160. 160. Ziegler M.G., Wilner K.D., Henry E.B. et al. Effects of sertraline on the betaadrenergic blooking activity of atenolol in healthy volunteers // Presented at XVIIIth CINP, Nice, France, June 28- July 2, 1992. 161. Zimmer A.W., Davie C.C., Fowles S.E. et al. Conducting clinical research in geriartic population // Ann. Intern. Med. – 1985. – Vol. 103. – P. 276-283. Copyright © Н.А.Корнетов © Сибирский вестник психиатрии и наркологии, 1988 |
Похожие:
 | Г. Б. Корнетов Корнетов Г. Б. Общая педагогика: Учебное пособие. 2-е изд., перераб и доп. – Асоу, 2009. – 296 с | | Программа по формированию навыков безопасного поведения на дорогах... Дикая В. И., Корнеев А. Н., Бологов П. В. Дифференцированный подход к терапии шизоаффективных психозов с преобладанием аффективных... |
| Проблемы роста депрессивных расстройств в условиях социально-экономической... В результате работы сделан вывод о недостаточности имеющихся медицинских мощностей (особенно в регионах) для работы с пациентами... |  | Влияние физических упражнений Поэтому физические упражнения являются средством неспецифической профилактики ряда функциональных расстройств и заболеваний, а лечебную... |
| Фармакогенетическое значение полиморфизмов гена β2-адренергического... Работа выполнена в гбоу впо первый Московский государственный медицинский университет им. И. М. Сеченова Минздрава России | | Д. В. Кандыба, В. М. Кандыба основы ск-терапии том 1 История ск-терапии Резервный день для прохождения гиа в новой форме в 9 классе по математике, истории России, биологии, физике |
| «Английский язык» Рекомендовано к изданию Ученым советом ано впо «Новый сибирский институт» (протокол №41 от 19. 06. 10) | | Игра искусства Перевод статьи выполнен по изданию: Gadamer H. G Редакция журнала и авторы Введения выражают благодарность издательству Mohr Siebeck GmbH & Co. Kg, г. Тюбинген за любезно предоставленное... |
| Программа дисциплины «Социальная психиатрия» Целью изучения дисциплины является овладение знаниями о влиянии факторов социальной среды на психическое здоровье, их связи с распространенностью,... | | Куттер Петер Элементы групповой терапии. Введение в психоаналитическую практику Охватывают многоуровневый комплекс наиболее часто повторяющихся, типичных экономических отношений между отдельными странами, их региональными... |
| Программа по формированию навыков безопасного поведения на дорогах... Представленная в списке литература раскрывает современные методы и техники терапии творчеством. Авторы делятся секретами использования... | | Практикум по креативной терапии [Текст]: учеб пособие / Зинкевич-Евстигнеева... Авторы делятся секретами использования сказкотерапии, арт-терапии, песочной терапии, игротерапии, анималотерапии и др. Отбор литературы... |
| «Русское общество и крестьянский вопрос в прошлом и настоящем России» России по крестьянской проблеме. Крестьянский вопрос являлся ключевым в политическом развитии, общественном движении России в XIX... | | Урок 5 Слои в Photoshop Скопируете фрагмент изображения, потом вставите его на рисунок и обнаружите, что вставился он не на тот же слой, а на новый. Или... |
| Курсовая Тема: «Отчет о движении денежных средств, его значение в... ... | | Урок литературы в 11 классе тема России в творчестве Александра Блока ... |
